| Anxiety Disorder |
1 |
1 |
| Anxiety |
0 |
0.92 |
| Generalized Anxiety Disorder |
0 |
0.68 |
| Separation Anxiety |
0 |
0.68 |
| Chronic Anxiety |
0 |
0.66 |
| Receptors |
0 |
0.29 |
| HIV Infection |
0 |
0.11 |
| Agitation |
0 |
0.1 |
| Neurotransmitters |
0 |
0.1 |
| SNRI |
0 |
0.09 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.08 |
| Dopamine |
0 |
0.08 |
| Histamine |
0 |
0.08 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.07 |
| Biologic Therapy |
0 |
0.06 |
| Central Nervous System |
0 |
0.06 |
| Depression |
0 |
0.06 |
| Genomic Medicine |
0 |
0.06 |
| Impairment |
0 |
0.06 |
| Muscle |
0 |
0.06 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.06 |
| Stress |
0 |
0.06 |
| Antipsychotics |
0 |
0.04 |
| Artery |
0 |
0.04 |
| Borderline Personality Disorder |
0 |
0.04 |
| Brain |
0 |
0.04 |
| Neuron |
0 |
0.04 |
| Pathogenesis |
0 |
0.04 |
| Post-Traumatic Stress Disorder |
0 |
0.04 |
| Schizophrenia |
0 |
0.04 |
| Sleep |
0 |
0.04 |
| Tardive Dyskinesia |
0 |
0.03 |
| Adverse Effects |
0 |
0.02 |
| Aggression |
0 |
0.02 |
| Antidepressant drug |
0 |
0.02 |
| Anxiolytic |
0 |
0.02 |
| Autonomic Nervous System |
0 |
0.02 |
| Blood |
0 |
0.02 |
| Dyskinesia |
0 |
0.02 |
| Genetics |
0 |
0.02 |
| Gland |
0 |
0.02 |
| Hyperarousal |
0 |
0.02 |
| Kidney |
0 |
0.02 |
| Kidney, Ureter, and Bladder |
0 |
0.02 |
| Memory |
0 |
0.02 |
| Panic Attack |
0 |
0.02 |
| Patient Safety |
0 |
0.02 |
| Personality Disorders |
0 |
0.02 |
| Physiology |
0 |
0.02 |
| Plasma |
0 |
0.02 |
| Platelet Count |
0 |
0.02 |
| Sexual Behavior |
0 |
0.02 |
| Spinal Cord |
0 |
0.02 |
| Trachea |
0 |
0.02 |
| Vein |
0 |
0.02 |